BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27147454)

  • 21. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value.
    Platzek I; Borkowetz A; Toma M; Brauer T; Meissner C; Dietel K; Wirth M; Laniado M
    J Comput Assist Tomogr; 2015; 39(5):674-80. PubMed ID: 25938212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.
    Tempany CM; Zhou X; Zerhouni EA; Rifkin MD; Quint LE; Piccoli CW; Ellis JH; McNeil BJ
    Radiology; 1994 Jul; 192(1):47-54. PubMed ID: 8208963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.
    Jung JA; Coakley FV; Vigneron DB; Swanson MG; Qayyum A; Weinberg V; Jones KD; Carroll PR; Kurhanewicz J
    Radiology; 2004 Dec; 233(3):701-8. PubMed ID: 15564406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods].
    Böni RA; Hutter BE; Trinkler F; Jochum W; Pestalozzi D; Krestin GP
    Rofo; 1996 Aug; 165(2):152-8. PubMed ID: 8924668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.
    Casciani E; Polettini E; Bertini L; Emiliozzi P; Amini M; Pansadoro V; Gualdi GF
    Radiol Med; 2004; 108(5-6):530-41. PubMed ID: 15722999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate.
    Choi H; Ma J
    AJR Am J Roentgenol; 2008 Apr; 190(4):1055-9. PubMed ID: 18356455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving SNR and B1 transmit field for an endorectal coil in 7 T MRI and MRS of prostate cancer.
    Arteaga de Castro CS; van den Bergen B; Luijten PR; van der Heide UA; van Vulpen M; Klomp DW
    Magn Reson Med; 2012 Jul; 68(1):311-8. PubMed ID: 22127763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
    Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
    Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study.
    Scheenen TW; Fütterer J; Weiland E; van Hecke P; Lemort M; Zechmann C; Schlemmer HP; Broome D; Villeirs G; Lu J; Barentsz J; Roell S; Heerschap A
    Invest Radiol; 2011 Jan; 46(1):25-33. PubMed ID: 21188832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
    Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
    Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 Tesla: should we use an endorectal coil?
    Yakar D; Heijmink SW; Hulsbergen-van de Kaa CA; Huisman H; Barentsz JO; Fütterer JJ; Scheenen TW
    Invest Radiol; 2011 May; 46(5):301-6. PubMed ID: 21217527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging.
    Beyersdorff D; Taymoorian K; Knösel T; Schnorr D; Felix R; Hamm B; Bruhn H
    AJR Am J Roentgenol; 2005 Nov; 185(5):1214-20. PubMed ID: 16247137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Staging and tissue characterization of prostate carcinoma: role of endorectal MR imaging and MR spectroscopy].
    Sugimura K
    Hinyokika Kiyo; 2000 Nov; 46(11):855-9. PubMed ID: 11193312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium enhanced endorectal coil and air enema magnetic resonance imaging as a useful tool in the preoperative examination of patients with rectal carcinoma.
    Matsuoka H; Masaki T; Sugiyama M; Nakamura A; Takahara T; Hachiya J; Atomi Y
    Hepatogastroenterology; 2004; 51(55):131-5. PubMed ID: 15011848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.
    Beyersdorff D; Taupitz M; Winkelmann B; Fischer T; Lenk S; Loening SA; Hamm B
    Radiology; 2002 Sep; 224(3):701-6. PubMed ID: 12202702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
    Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
    AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.